This clinical trial evaluates a new investigational varicella vaccine (chickenpox vaccine) and Priorix (a combination vaccine against measles, mumps, and rubella) when given as injections to healthy children aged 12 to 15 months. The study compares giving these vaccines through different injection methods – either into the muscle (intramuscular injection) or under the skin (subcutaneous injection).
The study aims to determine if the new chickenpox vaccine and Priorix work equally well when given as muscle injections compared to the standard under-the-skin method. The effectiveness will be measured by testing the body’s immune response to the vaccines through blood tests taken 43 days after vaccination.
During the study, participants will be monitored for common vaccination reactions like redness, pain, and swelling at the injection site, as well as general symptoms such as drowsiness, decreased appetite, irritability, and fever. They will also be checked for any rashes that may develop after vaccination. The total study duration will be 181 days, during which participants will have regular check-ups to monitor their health and any side effects.



Belgium
Bulgaria
Denmark
Estonia
Greece
Lithuania
Poland
Romania